Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19

Novel coronavirus disease 2019 (COVID-19) is known to cause severe pneumonia and acute respiratory distress syndrome which may lead to death. Several treatments have been tested in the race to find a treatment regimen for this deadly viral infection. Tocilizumab, a recombinant humanized anti-interle...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Steven Douedi, Moiuz Chaudhri, Jeffrey Miskoff
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Medknow Publications 2020-01-01
Serija:Annals of Thoracic Medicine
Teme:
covid-19
cytokine
interleukin-6
infection
monoclonal antibody
tocilizumab
Online dostop:http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2020;volume=15;issue=3;spage=171;epage=173;aulast=Douedi
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki